By rray, 31 October, 2023 Report adverse events to the Vaccine Adverse Event Reporting System https vaers hhs gov index html or 1 800 822 7967
By rray, 31 October, 2023 Contraindication Don t administer to those w hx of severe allergic reaction e g anaphylaxis to any component of the vaccine
By rray, 31 October, 2023 Precaution Delay vaccination for those experiencing moderate or severe acute illness w or w o fever
By rray, 31 October, 2023 When deciding whether to coadminister other vaccines w an RSV vaccine consider whether the pt is current w recommended vaccines the feasibility of the pt returning for additional vaccine doses the risk for acquiring vaccine preventable dz vaccine reactoge
By rray, 31 October, 2023 Coadministration may increase local or systemic reactogenicity However data are available only for the coadministration of RSV and influenza vaccines and the evidence is mixed
By rray, 31 October, 2023 When administering 1 vaccine at the same visit separate injection sites by 1 inch if possible For vaccines associated w an enhanced local reaction consider administering in separate limbs
By rray, 31 October, 2023 Administration of RSV vaccines w other adult vaccines during the same visit is acceptable nbsp Coadministration of RSV and seasonal influenza vaccines met noninferiority criteria for immunogenicity w the exception of the FluA Darwin H3N2 strain when RSVPr
By rray, 31 October, 2023 Optimally vaccination should occur before the onset of RSV season As soon as vaccine supply becomes available offer vaccination to adults 60 yo using shared clinical decision making continue to offer vaccination to eligible adults who remain unvaccinated